Tags |
|
|
Links |
|
|
Just Other Articles - Visa Vs MasterCard – Which Is The Best?
The two leading credit card companies in the world today are the competitors Visa and MasterCard. They both opera
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
te along very similar lines. While Visa can claim to have almost a billion cards issued, MasterCard has over twen
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
y five thousand banks issuing its cards and it is difficult to find any difference in the number of locations wor
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
dwide that accept the cards, which is now estimated at over twenty million.
In fact, as far as most consumers ar
In fact, as far as most consumers ar
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
concerned, there is no real difference between the two. They are both very widely accepted in over one hundred a
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
d fifty countries and it is very rare to find a location that will accept one but not the other.
However, neithe
However, neithe
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
Visa nor MasterCard actually issue any credit cards themselves. They are both simply methods of payment. They re
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
y on banks in various countries to issue credit cards that utilise these payment methods. Therefore, the interest
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rates, rewards, annual fees, and all other charges are issued by your bank and when you pay your bill you are pay
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ng it to the bank or institution that issued your card and not Visa or MasterCard.
How Visa and MasterCard make
How Visa and MasterCard make
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
heir money is by charging the retailer for using their payment method. So the truth of the matter is that a Visa
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
issued by say the Bank of Scotland will have very little to do with a Visa issued by other banks and may in fact
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
y more similar to the Bank of Scotland’s MasterCard.
What this means for the vast majority of customers is that
What this means for the vast majority of customers is that
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ou do not have to overly concern yourself with whether a credit card is MasterCard or Visa. You would be better o
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
f concentrating on the interest and other charges on the card, the balance transfer possibilities or their reward
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
scheme. You are very unlikely to ever be effected by the fact that it is one and not the other.
If you prefer, i
If you prefer, i
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
you are going to have two credit cards, you may decide that you want one of them to be Visa and the other Master
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ard, this means that if something drastic were to happen to one company, or if you were in the unlikely position
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
f finding a location that accepts one but not the other, then you would have the option of paying with either.
A
A
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
the end of the day however, much more depends on the bank that gave you the card, than on the type of card it is
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/92006/justotherarticles-Visa-Vs-MasterCard--Which-Is-The-Best.html">Visa Vs MasterCard – Which Is The Best?</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/92006/justotherarticles-Visa-Vs-MasterCard--Which-Is-The-Best.html]Visa Vs MasterCard – Which Is The Best?[/url]
Related Articles:
He Who Hesitates Waits... and Waits... and Waits... and Waits
Selling While Shackled By Professionalism
Content is King, Links are Queens
Bookmark it:
|